|
What factors impact the formation of 1-cyclopentyl-4-nitrosopiperazine (CPNP) by rifapentine
|
|
0
|
333
|
October 31, 2023
|
|
Variation requirements
|
|
2
|
488
|
October 2, 2023
|
|
Apixaban Drug Substance-Related Impurities (NDSRIs)
|
|
3
|
1761
|
September 15, 2023
|
|
Considerations for high-risk unit operations
|
|
2
|
571
|
August 18, 2023
|
|
Nitrosamines from tertiary amines in azabicycles
|
|
4
|
475
|
June 9, 2023
|
|
IPEC Nitrosamine Questionnaire Q&A Excipients
|
|
6
|
1274
|
June 8, 2023
|
|
A Nitrite Excipient Database: A Useful Tool to Support N-Nitrosamine Risk Assessments for Drug Products
|
|
1
|
1016
|
June 5, 2023
|
|
Setting limit for Nitrite and Nitrate in water used for Active Ingredients synthesis
|
|
2
|
1688
|
May 23, 2023
|
|
Indigo carmine as secondary amine?
|
|
7
|
819
|
May 16, 2023
|
|
The true role of NitrXtes in NDSRIs?
|
|
2
|
472
|
April 3, 2023
|
|
A Survey of Industrial N-nitrosamine Discharges in Switzerland -Pub
|
|
0
|
335
|
March 1, 2023
|
|
Prediction of Nitrosamine formation from Excipients
|
|
19
|
1881
|
February 8, 2023
|
|
Nitrosamine risks that may arise from the filters
|
|
2
|
885
|
January 4, 2023
|
|
Calcium Phosphate- Opadry-Lhasa
|
|
0
|
441
|
December 21, 2022
|
|
E&L challenges and pitfalls in connection with NAs & NDRSIs
|
|
0
|
378
|
December 12, 2022
|
|
Drug-Nitrite interaction products -Publication review
|
|
2
|
740
|
November 30, 2022
|
|
Nitrocellulose blister material as a source of N-nitrosamine (peer-review-article)
|
|
2
|
1359
|
September 1, 2022
|
|
API seem to form N-nitrosamines upon oxidation (e.g. air) and without the presence of nitrosonium ions
|
|
1
|
716
|
August 4, 2022
|
|
Exact Root causes for NDMA in Metformin & NDSRI's Impurities in Varenicline, Quinapril & Orphenadrine
|
|
4
|
1126
|
July 7, 2022
|
|
Risk of Nitrosamine Formation from Nitrites in Aqueous Systems
|
|
0
|
697
|
June 27, 2022
|
|
A Nitrite Excipient Database - Risk Assessment
|
|
6
|
2186
|
June 15, 2022
|
|
Drug substance-related impurities (NDSRIs) in Drug product and Drug substances
|
|
7
|
3421
|
June 8, 2022
|
|
Anybody dealing with Nitrosopiparazines?
|
|
1
|
447
|
June 7, 2022
|
|
FDA Root Causes of Nitrosamines Formation Fellowship
|
|
0
|
314
|
April 14, 2022
|
|
Risk of Nitrosamine in packaging materials, risk or control?
|
|
2
|
1869
|
April 1, 2022
|
|
NDMA in German Beer - A success Story
|
|
1
|
341
|
January 25, 2022
|
|
Excipients, morpholine?
|
|
4
|
382
|
October 18, 2021
|
|
Nitrosamines - Elastomers perspective (PDA publication)
|
|
8
|
792
|
October 16, 2021
|
|
Results from survey on Nitrosamines in Excipients -Any thoughts?
|
|
10
|
805
|
September 23, 2021
|
|
Excipient & Nitrosamines -Q&A session
|
|
0
|
342
|
September 16, 2021
|